 Entera Bio Ltd. ENTX the Company or Entera, a global innovator in drug delivery platforms, announced today it has closed a private placement offering the Offering with a select group of accredited investors, including certain board members or their affiliates the Purchasers, under which it received gross proceeds of 11.8 million from the sale of 4,982,301 ordinary shares, par value NIS 0.0000769 per share at a price of 2.37 per share the Shares. In addition, the Company has granted the Purchasers and certain finders an aggregate of 2,693,573 three-year warrants to purchase up to an additional 2,693,573 ordinary shares at an exercise price between 2.37 and 2.96 per share the Warrants and together with the Shares, the Securities. 